• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

瓦努阿图的细菌学与抗菌药物耐药性：2017年1月至2019年12月

Bacteriology and Antimicrobial Resistance in Vanuatu: January 2017 to December 2019.

作者信息

Foxlee Nicola D, Townell Nicola, Tosul Mary Ann L, McIver Lachlan, Lau Colleen L

机构信息

Department of Global Health, Research School of Population Health, Australian National University, Canberra, ACT 2600, Australia.

Diagnostic Microbiology Development Program, Phnom Penh 12000, Cambodia.

出版信息

Antibiotics (Basel). 2020 Mar 31;9(4):151. doi: 10.3390/antibiotics9040151.

DOI:10.3390/antibiotics9040151
PMID:32244420
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7235848/
Abstract

drug resistance; antimicrobial; public health surveillance; Pacific Islands; bacteriology; epidemiology.

摘要

耐药性；抗菌药物；公共卫生监测；太平洋岛屿；细菌学；流行病学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ef/7235848/64931b885b66/antibiotics-09-00151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ef/7235848/856c73a6131d/antibiotics-09-00151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ef/7235848/64931b885b66/antibiotics-09-00151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ef/7235848/856c73a6131d/antibiotics-09-00151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69ef/7235848/64931b885b66/antibiotics-09-00151-g002.jpg

相似文献

1
Bacteriology and Antimicrobial Resistance in Vanuatu: January 2017 to December 2019.瓦努阿图的细菌学与抗菌药物耐药性：2017年1月至2019年12月
Antibiotics (Basel). 2020 Mar 31;9(4):151. doi: 10.3390/antibiotics9040151.
2
The case for investing in family planning in the Pacific: costs and benefits of reducing unmet need for contraception in Vanuatu and the Solomon Islands.投资太平洋地区计划生育的理由：减少瓦努阿图和所罗门群岛避孕未满足需求的成本和效益。
Reprod Health. 2013 Jun 10;10:30. doi: 10.1186/1742-4755-10-30.
3
Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands.在瓦努阿图和所罗门群岛的南太平洋岛屿引入青蒿素联合疗法时，pfcrt和pfmdr1基因的突变情况。
Malar J. 2014 Oct 15;13:406. doi: 10.1186/1475-2875-13-406.
4
First marine litter survey on beaches in Solomon Islands and Vanuatu, South Pacific: Using OSPAR protocol to inform the development of national action plans to tackle land-based solid waste pollution.南太平洋所罗门群岛和瓦努阿图海滩的首次海洋垃圾调查：利用 OSPAR 议定书为制定国家行动计划以解决陆基固体废物污染提供信息。
Mar Pollut Bull. 2020 Dec;161(Pt A):111827. doi: 10.1016/j.marpolbul.2020.111827. Epub 2020 Nov 16.
5
Brucella abortus surveillance of cattle in Fiji, Papua New Guinea, Vanuatu, the Solomon Islands and a case for active disease surveillance as a training tool.斐济、巴布亚新几内亚、瓦努阿图、所罗门群岛牛群布鲁氏菌病流产亚种监测以及将主动疾病监测作为培训工具的案例
Trop Anim Health Prod. 2016 Oct;48(7):1471-81. doi: 10.1007/s11250-016-1120-8. Epub 2016 Aug 13.
6
Chikungunya virus (CHIKV) seroprevalence in the South Pacific populations of the Cook Islands and Vanuatu with associated environmental and social factors.基孔肯雅热病毒（CHIKV）在库克群岛和瓦努阿图南太平洋人群中的血清流行率及相关环境和社会因素。
PLoS Negl Trop Dis. 2022 Nov 28;16(11):e0010626. doi: 10.1371/journal.pntd.0010626. eCollection 2022 Nov.
7
High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.CYP2C19突变的高频率及变异性：瓦努阿图和其他太平洋岛屿药物代谢不良的医学后果
Pharmacogenetics. 1999 Oct;9(5):581-90.
8
Challenges to implementation and strengthening of initial COVID-19 surveillance in Vanuatu: January-April 2020.2020 年 1 月至 4 月期间，瓦努阿图在实施和加强 COVID-19 初步监测方面面临的挑战。
Western Pac Surveill Response J. 2021 Apr 5;12(2):57-64. doi: 10.5365/wpsar.2020.11.2.012. eCollection 2021 Apr-Jun.
9
Rocketship and the Rural Health Workforce Revolution in the Pacific: Growing Skilled Medical Generalists Across the "Blue Continent".火箭飞船与太平洋地区农村卫生人力革命：在“蓝色大陆”培养技术娴熟的全科医生
Front Public Health. 2021 Feb 3;8:612531. doi: 10.3389/fpubh.2020.612531. eCollection 2020.
10
Assessing intertidal seagrass beds relative to water quality in Vanuatu, South Pacific.评估南太平洋瓦努阿图潮间带海草床与水质的关系。
Mar Pollut Bull. 2021 Feb;163:111936. doi: 10.1016/j.marpolbul.2020.111936. Epub 2020 Dec 23.

引用本文的文献

1
Genomic diversity of clinically relevant bacterial pathogens from an acute care hospital in Suva, Fiji.来自斐济苏瓦一家急症医院的临床相关细菌病原体的基因组多样性。
JAC Antimicrob Resist. 2025 Jun 9;7(3):dlaf058. doi: 10.1093/jacamr/dlaf058. eCollection 2025 Jun.
2
Establishing carbapenem resistant organism surveillance, prevention, and control in a middle-income country: implementation of a hospital-based program in Fiji.在一个中等收入国家建立碳青霉烯类耐药菌监测、预防和控制体系：斐济一项基于医院项目的实施情况
Antimicrob Resist Infect Control. 2025 Mar 5;14(1):19. doi: 10.1186/s13756-025-01534-5.
3
The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019-2022.

本文引用的文献

1
Quality microbiological diagnostics and antimicrobial susceptibility testing, an essential component of antimicrobial resistance surveillance and control efforts in Pacific island nations.高质量的微生物诊断和抗菌药物敏感性测试，是太平洋岛国抗菌药物耐药性监测与控制工作的重要组成部分。
Western Pac Surveill Response J. 2020 Feb 20;11(1):41-46. doi: 10.5365/wpsar.2018.9.3.004. eCollection 2020 Jan-Mar.
2
Australia's response to the global threat of antimicrobial resistance: past, present and future.澳大利亚对抗菌素耐药性全球威胁的应对：过去、现在与未来。
Med J Aust. 2019 Aug;211(3):106-108.e1. doi: 10.5694/mja2.50264. Epub 2019 Jul 16.
3
斐济抗菌药物耐药性的流行病学变化：2019 - 2022年地方性病原体和新出现病原体的抗菌药物敏感性及趋势描述性分析
Lancet Reg Health West Pac. 2024 Mar 14;45:101036. doi: 10.1016/j.lanwpc.2024.101036. eCollection 2024 Apr.
4
The Impact of COVID-19 on Knowledge, Beliefs, and Practices of Ni-Vanuatu Health Workers Regarding Antibiotic Prescribing and Antibiotic Resistance, 2018 and 2022: A Mixed Methods Study.2018年和2022年新冠疫情对瓦努阿图卫生工作者在抗生素处方和抗生素耐药性方面的知识、信念及实践的影响：一项混合方法研究
Trop Med Infect Dis. 2023 Oct 18;8(10):477. doi: 10.3390/tropicalmed8100477.
5
Ertapenem Supplemented Selective Media as a New Strategy to Distinguish β-Lactam-Resistant Enterobacterales: Application to Clinical and Wastewater Samples.厄他培南补充选择性培养基作为区分耐β-内酰胺肠杆菌科细菌的新策略：在临床和废水样本中的应用
Antibiotics (Basel). 2023 Feb 15;12(2):392. doi: 10.3390/antibiotics12020392.
6
Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017-2021.2017 - 2021年四个太平洋岛国临床标本中分离出的细菌的抗菌药敏性
Lancet Reg Health West Pac. 2023 Feb 2;32:100677. doi: 10.1016/j.lanwpc.2022.100677. eCollection 2023 Mar.
Global geographic trends in antimicrobial resistance: the role of international travel.
全球抗菌药物耐药性的地理趋势：国际旅行的作用。
J Travel Med. 2019 Dec 23;26(8). doi: 10.1093/jtm/taz036.
4
Antibiotic Resistance in Pacific Island Countries and Territories: A Systematic Scoping Review.太平洋岛国及领地的抗生素耐药性：一项系统综述
Antibiotics (Basel). 2019 Mar 19;8(1):29. doi: 10.3390/antibiotics8010029.
5
Clinical bacteriology in low-resource settings: today's solutions.低资源环境下的临床细菌学：今日的解决方案。
Lancet Infect Dis. 2018 Aug;18(8):e248-e258. doi: 10.1016/S1473-3099(18)30093-8. Epub 2018 Mar 5.
6
Review of antibiotic resistance in China and its environment.中国抗生素耐药性及其环境综述。
Environ Int. 2018 Jan;110:160-172. doi: 10.1016/j.envint.2017.10.016. Epub 2017 Oct 27.
7
The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.新西兰产碳青霉烯酶肠杆菌科细菌（CPE）的明显且当前存在的危险：制定国家应对计划的时候到了。
N Z Med J. 2017 Apr 28;130(1454):72-79.
8
Pacific Island Countries and Climate Change: Examining Associated Human Health Vulnerabilities.太平洋岛国与气候变化：审视相关的人类健康脆弱性
Environ Health Perspect. 2016 Nov 1;124(11):A208. doi: 10.1289/ehp.124-A208.
9
Preventing Hospital-acquired Infections in Low-income and Middle-income Countries: Impact, Gaps, and Opportunities.在低收入和中等收入国家预防医院获得性感染：影响、差距与机遇
Infect Dis Clin North Am. 2016 Sep;30(3):805-18. doi: 10.1016/j.idc.2016.04.006.
10
Missing in action: an antimicrobial resistance strategy for New Zealand.行动缺失：新西兰的一项抗菌药物耐药性策略。
N Z Med J. 2015 Dec 18;128(1427):65-7.